Yuhan Chang

6PUBLICATIONS
10CO-AUTHORS
Molecular targetsDynamics, vibration and vibration controlPredictive and prognostic markersEnergy generation, conversion and storage (excl. chemical and electrical)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 18, 2026
Targeting AHNAK ameliorates osteonecrosis of the femoral head and affects adipogenic pathways involving Smad/PPARγ.

|Mar 18, 2026
Targeting EFEMP1 enhances chondrogenesis and inhibits hypertrophic differentiation in a spontaneous osteoarthritis mouse model.

Yuhan Chang, Pei-Heng Jiang, Yung-Heng Hsu

|Mar 03, 2026
CXCL5 suppresses osteoclastogenesis and protects against lipoteichoic acid-induced bone loss by modulating PLCγ2 and c-Fos signalling in gram-positive periprosthetic joint infection.

Yuhan Chang, Pei-Heng Jiang, Yung-Heng Hsu

|Dec 11, 2023
The role of EDIL3 in maintaining cartilage extracellular matrix and inhibiting osteoarthritis development.

Mei-Feng Chen, Chih-Chien Hu, Yung-Heng Hsu

|May 16, 2023
Characterization and Advancement of an Evaluation Method for the Treatment of Spontaneous Osteoarthritis in STR/ort Mice: GRGDS Peptides as a Potential Treatment for Osteoarthritis.

Mei-Feng Chen, Chih-Chien Hu, Yung-Heng Hsu

|Oct 31, 2021
Treatment of knee osteoarthritis with intra-articular injection of allogeneic adipose-derived stem cells (ADSCs) ELIXCYTE®: a phase I/II, randomized, active-control, single-blind, multiple-center clinical trial.

Cheng-Fong Chen, Chih-Chien Hu, Chen-Te Wu

Pageof 1

Frequent Collaborators

5 joint publications

Mei-Feng Chen

4 joint publications

Chih-Chien Hu

4 joint publications

Yung-Heng Hsu

3 joint publications

Pei-Heng Jiang